ARTICLE | Clinical News
NeurotrophinCell: Phase I/IIa data
November 9, 2015 8:00 AM UTC
Data from 4 PD patients in an open-label, New Zealand Phase I/IIa trial showed NtCell injected into the brain stopped disease progression and significantly improved neurological scores in all 4 patien...